Asian Growth Companies With High Insider Ownership In March 2025

In March 2025, Asian markets have been navigating a complex landscape marked by global trade tensions and economic policy shifts, with China signaling potential stimulus measures to maintain its growth targets. Amid this backdrop, identifying growth companies with high insider ownership can be an attractive strategy, as such ownership often aligns management's interests with those of shareholders and may indicate confidence in the company's future prospects.

Advertisement

Top 10 Growth Companies With High Insider Ownership In Asia

NameInsider OwnershipEarnings Growth
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)23.3%26%
Seojin SystemLtd (KOSDAQ:A178320)32.1%39.9%
Laopu Gold (SEHK:6181)36.4%43.7%
Global Tax Free (KOSDAQ:A204620)20.4%89.3%
Suzhou Sunmun Technology (SZSE:300522)35.4%92.8%
Techwing (KOSDAQ:A089030)18.8%64.3%
HANA Micron (KOSDAQ:A067310)18.3%125.9%
Fulin Precision (SZSE:300432)13.6%78.6%
Ascentage Pharma Group International (SEHK:6855)17.9%60.9%
Synspective (TSE:290A)13.2%37.4%

Click here to see the full list of 637 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Kuaishou Technology (SEHK:1024)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Kuaishou Technology is an investment holding company offering live streaming, online marketing, and other services in the People’s Republic of China with a market cap of HK$270.82 billion.

Operations: The company generates revenue from its domestic operations amounting to CN¥119.83 billion and overseas activities contributing CN¥4.25 billion.

Insider Ownership: 19.6%

Kuaishou Technology is experiencing rapid growth, with earnings surging over 1,000% last year and forecasted to grow annually by 16.33%, outpacing the Hong Kong market. The company trades at a good value compared to peers, priced 22.1% below its fair value estimate. Recent innovations like Kling AI's multi-image reference feature enhance creative capabilities and expand monetization efforts, while insider ownership remains stable without substantial recent trading activity.

SEHK:1024 Ownership Breakdown as at Mar 2025
SEHK:1024 Ownership Breakdown as at Mar 2025

BYD (SEHK:1211)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BYD Company Limited, along with its subsidiaries, operates in the automobiles and batteries sectors across China, Hong Kong, Macau, Taiwan, and internationally, with a market cap of HK$1.13 trillion.

Operations: BYD's revenue is primarily derived from its automobiles and batteries segments, operating across the People's Republic of China, Hong Kong, Macau, Taiwan, and international markets.

Insider Ownership: 28.8%

BYD demonstrates strong growth potential, with earnings expected to grow at 17.8% annually, surpassing the Hong Kong market's average. Recent production volumes reflect significant increases compared to last year, underscoring robust operational expansion. The recent HK$43.51 billion follow-on equity offering supports further growth initiatives. BYD's strategic expansion in the UK and energy storage projects in Nebraska highlight its commitment to innovation and sustainability, though insider trading activity remains minimal over the past three months.

SEHK:1211 Ownership Breakdown as at Mar 2025
SEHK:1211 Ownership Breakdown as at Mar 2025

Shanghai Runda Medical Technology (SHSE:603108)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Shanghai Runda Medical Technology Co., Ltd. operates in the medical technology sector and has a market cap of approximately CN¥14.06 billion.

Operations: Shanghai Runda Medical Technology Co., Ltd. generates its revenue through various segments in the medical technology sector.

Insider Ownership: 16%

Shanghai Runda Medical Technology shows promising growth prospects, with earnings expected to grow significantly at 67.2% annually, outpacing the Chinese market's average. Despite a volatile share price and declining profit margins, the company trades at good value relative to its peers. Revenue is projected to increase by 13.6% per year, slightly above market expectations. While insider trading data over the past three months is unavailable, substantial insider ownership aligns interests with shareholders' long-term goals.

SHSE:603108 Ownership Breakdown as at Mar 2025
SHSE:603108 Ownership Breakdown as at Mar 2025

Where To Now?

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SHSE:603108

Shanghai Runda Medical Technology

Shanghai Runda Medical Technology Co., Ltd.

Mediocre balance sheet and slightly overvalued.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5360.5% undervalued
136 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18053.1% undervalued
20 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.315.7% undervalued
11 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2454.2% undervalued
31 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

QU
QuanD
AMD logo
QuanD on Advanced Micro Devices ·

Gaining Ground on Nvidia

Fair Value:US$274.3162.4% overvalued
42 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
MA
MarkoVT
5253 logo
MarkoVT on COVER ·

Significant headwinds will temper expectations for FY2027

Fair Value:JP¥2.28k37.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
UNCY logo
kapirey on Unicycive Therapeutics ·

Unicycive Therapeutics is a late-stage clinical biotech transitioning toward commercialization

Fair Value:US$9.177.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.8% undervalued
108 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.226.0% undervalued
70 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74016.7% undervalued
37 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative